Related Experiment Video
Updated: Jul 3, 2026
07:52
A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
Published on: November 7, 2017
Chronic kidney disease, heart failure and anemia
Sean A Virani1, Amit Khosla, Adeera Levin
1University of British Columbia, Vancouver, British Columbia.
The Canadian Journal of Cardiology
|July 17, 2008
Summary
The combination of chronic kidney disease, heart failure, and anemia worsens patient prognosis. Treating erythropoietin deficiency is key for improving cardiovascular outcomes in these patients.
Area of Science:
- Nephrology
- Cardiology
- Hematology
Background:
- The co-occurrence of chronic kidney disease (CKD), heart failure (HF), and anemia is common.
- This triad significantly increases morbidity and mortality.
- Anemia may be a unifying factor explaining poor outcomes in CKD and HF patients.
Purpose of the Study:
- To explore the relationship between anemia, CKD, and HF.
- To evaluate the impact of erythropoietin-stimulating agents (ESAs) on cardiovascular outcomes.
- To identify optimal treatment strategies for anemia in CKD and HF patients.
Main Methods:
- Review of observational and interventional trials involving ESAs.
- Analysis of data on erythropoietin deficiency and hemoglobin levels.
- Focus on cardiovascular end points in patients with CKD and HF.
Main Results:
- ESA trials have yielded variable results regarding cardiovascular end points.
- Emerging data suggest treating erythropoietin deficiency is crucial.
- The absolute hemoglobin level achieved may be less important than addressing the deficiency itself.
Conclusions:
- The triad of CKD, HF, and anemia indicates a poor prognosis.
- Optimal management requires addressing erythropoietin deficiency.
- Future research should focus on optimal ESA dosing and target hemoglobin levels for improved cardiovascular outcomes.
Related Concept Videos
01:24Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
01:18Chronic Kidney Disease IV: Nursing Management
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...
01:25Chronic Kidney Disease I: Introduction
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
01:28Chronic Kidney Disease III: Interprofessional Care
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
01:27Heart Failure I: Introduction
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
01:22Heart Failure Drugs: Diuretics
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...